Category Archives: Recent News

BriaCell Announces Publication at American Society of Clinical Oncology (ASCO) Meeting and Presentation at Precision Breast Cancer Summit in Boston
April 23, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, April 23, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell’s Lead Candidate Combined With KEYTRUDA®: Strong Evidence of Rapid Additive or Synergistic Anti-Tumor Activity
April 3, 2019

• As presented at the American Association for Cancer Research (AACR) annual meeting: early efficacy ...

BriaCell Announces Clinical Trial Collaboration Agreement with Incyte
April 2, 2019

· BriaCell Therapeutics and Incyte have formed a non-exclusive clinical trial collaboration to evaluate the ...

BriaCell Announces Closing of Upsized & Oversubscribed Non-Brokered Private Placement of $2.97 Million
April 1, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, April 1, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell to Announce Early Efficacy Data of Lead Candidate in Combination with KEYTRUDA® at AACR Annual Meeting
March 26, 2019

• Early data of BriaCell’s combination study of lead candidate, Bria-IMT™, with KEYTRUDA® (by Merck ...

BriaCell Closes First Tranche of Previously Announced Non-Brokered Private Placement
March 25, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, March 25, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces $2,000,000 Non-Brokered Private Placement Offering
March 20, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, March 20, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Welcomes BioPharma Industry Experts to its Board of Directors
March 18, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, March 18, 2019 – BriaCell® Therapeutics Corp. (“BriaCell®” or ...

BriaCell Announces C$500,000 Equity Investment by BriaCell Director
February 26, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, February 26, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell to Present Clinical and Scientific Findings with New Insights at Key Oncology Conferences
February 19, 2019

· New insights into BriaDX™, BriaCell’s simple patient HLA-type identification test, will be presented at ...

Skip to content